Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice
© 2018 The Author(s). Published by S. Karger AG, Basel..
BACKGROUND/AIMS: Excessive fluoride intake can induce cytotoxicity, DNA damage and cell-cycle changes in many tissues and organs, including the kidney. However, the underlying molecular mechanisms of fluoride-induced renal cell-cycle changes are not well understood at present. In this study, we used a mouse model to investigate how sodium fluoride (NaF) induces cell-cycle changes in renal cells.
METHODS: Two hundred forty ICR mice were randomly assigned to four equal groups for intragastric administration of NaF (0, 12, 24 and 48 mg/kg body weight/day) for 42 days. Kidneys were taken to measure changes of the cell-cycle at 21 and 42 days of the experiment, using flow cytometry, quantitative real-time polymerase chain reaction (qRT-PCR) and western blot methods.
RESULTS: NaF, at more than 12 mg/kg body weight, induced G2/M phase cell-cycle arrest in the renal cells, which was supported by the finding of significantly increased percentages of renal cells in the G2/M phase. We found also that G2/M phase cell-cycle arrest was accompanied by up-regulation of p-ATM, p-Chk2, p-p53, p-Cdc25C, p-CDK1, p21, and Gadd45a protein expression levels; up-regulation of ATM, Chk2, p53, p21, and Gadd45a mRNA expression levels; down-regulation of CyclinB1, mdm2, PCNA protein expression levels; and down-regulation of CyclinB1, CDK1, Cdc25C, mdm2, and PCNA mRNA expression levels.
CONCLUSION: In this mouse model, NaF, at more than 12 mg/ kg, induced G2/M phase cell-cycle arrest by activating the ATM-Chk2-p53/Cdc25C signaling pathway, which inhibits the proliferation of renal cells and development of the kidney. Activation of the ATM-Chk2-p53/Cdc25C signaling pathway is the mechanism of NaF-induced renal G2/M phase cell-cycle arrest in this model.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 51(2018), 5 vom: 10., Seite 2421-2433 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Luo, Qin [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.01.2019 Date Revised 12.02.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1159/000495899 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM291678734 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM291678734 | ||
003 | DE-627 | ||
005 | 20231225071414.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000495899 |2 doi | |
028 | 5 | 2 | |a pubmed24n0972.xml |
035 | |a (DE-627)NLM291678734 | ||
035 | |a (NLM)30537743 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Luo, Qin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.01.2019 | ||
500 | |a Date Revised 12.02.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2018 The Author(s). Published by S. Karger AG, Basel. | ||
520 | |a BACKGROUND/AIMS: Excessive fluoride intake can induce cytotoxicity, DNA damage and cell-cycle changes in many tissues and organs, including the kidney. However, the underlying molecular mechanisms of fluoride-induced renal cell-cycle changes are not well understood at present. In this study, we used a mouse model to investigate how sodium fluoride (NaF) induces cell-cycle changes in renal cells | ||
520 | |a METHODS: Two hundred forty ICR mice were randomly assigned to four equal groups for intragastric administration of NaF (0, 12, 24 and 48 mg/kg body weight/day) for 42 days. Kidneys were taken to measure changes of the cell-cycle at 21 and 42 days of the experiment, using flow cytometry, quantitative real-time polymerase chain reaction (qRT-PCR) and western blot methods | ||
520 | |a RESULTS: NaF, at more than 12 mg/kg body weight, induced G2/M phase cell-cycle arrest in the renal cells, which was supported by the finding of significantly increased percentages of renal cells in the G2/M phase. We found also that G2/M phase cell-cycle arrest was accompanied by up-regulation of p-ATM, p-Chk2, p-p53, p-Cdc25C, p-CDK1, p21, and Gadd45a protein expression levels; up-regulation of ATM, Chk2, p53, p21, and Gadd45a mRNA expression levels; down-regulation of CyclinB1, mdm2, PCNA protein expression levels; and down-regulation of CyclinB1, CDK1, Cdc25C, mdm2, and PCNA mRNA expression levels | ||
520 | |a CONCLUSION: In this mouse model, NaF, at more than 12 mg/ kg, induced G2/M phase cell-cycle arrest by activating the ATM-Chk2-p53/Cdc25C signaling pathway, which inhibits the proliferation of renal cells and development of the kidney. Activation of the ATM-Chk2-p53/Cdc25C signaling pathway is the mechanism of NaF-induced renal G2/M phase cell-cycle arrest in this model | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ATM-Chk2-p53/Cdc25C signaling pathway | |
650 | 4 | |a G2/M phase arrest | |
650 | 4 | |a Kidney | |
650 | 4 | |a Mice | |
650 | 4 | |a Proliferation | |
650 | 4 | |a Sodium fluoride | |
650 | 7 | |a Tumor Suppressor Protein p53 |2 NLM | |
650 | 7 | |a Sodium Fluoride |2 NLM | |
650 | 7 | |a 8ZYQ1474W7 |2 NLM | |
650 | 7 | |a Checkpoint Kinase 2 |2 NLM | |
650 | 7 | |a EC 2.7.1.11 |2 NLM | |
650 | 7 | |a Ataxia Telangiectasia Mutated Proteins |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Atm protein, mouse |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Chek2 protein, mouse |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Cdc25c protein, mouse |2 NLM | |
650 | 7 | |a EC 3.1.3.48 |2 NLM | |
650 | 7 | |a cdc25 Phosphatases |2 NLM | |
650 | 7 | |a EC 3.1.3.48 |2 NLM | |
700 | 1 | |a Guo, Hongrui |e verfasserin |4 aut | |
700 | 1 | |a Kuang, Ping |e verfasserin |4 aut | |
700 | 1 | |a Cui, Hengmin |e verfasserin |4 aut | |
700 | 1 | |a Deng, Huidan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Huan |e verfasserin |4 aut | |
700 | 1 | |a Lu, Yujiao |e verfasserin |4 aut | |
700 | 1 | |a Wei, Qin |e verfasserin |4 aut | |
700 | 1 | |a Chen, Linlin |e verfasserin |4 aut | |
700 | 1 | |a Fang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Zuo, Zhicai |e verfasserin |4 aut | |
700 | 1 | |a Deng, Junliang |e verfasserin |4 aut | |
700 | 1 | |a Li, Yinglun |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xun |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Ling |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology |d 1996 |g 51(2018), 5 vom: 10., Seite 2421-2433 |w (DE-627)NLM090692519 |x 1421-9778 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2018 |g number:5 |g day:10 |g pages:2421-2433 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000495899 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 51 |j 2018 |e 5 |b 10 |h 2421-2433 |